NYSE · Drug Manufacturers - Specialty & Generic

Hims Hers Health Inc (HIMS)

$14.60 -8.86%
27 Oversold Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 50$26.51-44.93%
SMA 200$26.91-45.75%
EMA 20$21.49-32.06%

Company profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$5.35B
P/E ratioNone
EPS$-0.64
Beta2.502
Dividend yield0.00%
52-week high$40.99
52-week low$13.74

Insider transactions

ExecutiveTitleActionSharesDate
BOUGHTON, SOLEILChief Legal OfficerS3,4622026-10-28
BOUGHTON, SOLEILChief Legal OfficerS3,4612026-10-14
OKUPE, OLUYEMIChief Financial OfficerS2,0002026-10-01
Sign in: free for 30 days

Latest news

Earnings call transcript

Q3 2026

Hello, everyone. Thank you for joining us, and welcome to the Hims & Hers Health Third Quarter 2026 Earnings Call. I will now hand the conference over to Bill Newby, Director of Investor Relations. Bill, please go ahead.…

Sign in: free for 30 days

Options chain

TypeStrikeExpiryVolumeOpen interest
Call$20.002026-11-203,8196,027
Call$21.002026-11-202,3626,095
Call$21.002026-11-271,7521,040
Sign in: free for 30 days

ETFs holding HIMS

Similar stocks in Drug Manufacturers - Specialty & Generic

30 days of PRO Unlimited free, no card

RSI alerts for HIMS

An email when HIMS closes below RSI 30 or above 70. Nothing else.

Data last updated 21 November 2026 at 9:09 PM EST